# HIT (Health In Tech, Inc.) - SEC EDGAR Financial Statements

> Health In Tech, Inc. reported $30.92M in revenue and a net loss of $11.47M for the trailing twelve months ended September 30, 2026 (down 22.4% year over year), with a 50.5% gross margin and a -45.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/HIT
- Markdown: https://convexityos.com/fundamentals/HIT.md
- SEC CIK: 0002019505
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:01 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002019505&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $30.92M | -22.4% YoY |
| Operating Income | TTM | -$14.16M | -45.8% margin |
| Net Income | TTM | -$11.47M | -37.1% net margin |
| Diluted EPS | TTM | -$0.18 | Split-adjusted |
| Free Cash Flow | TTM | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | -- | Total debt: $84K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Revenue** | $33.33M | $19.49M | $19.15M |
| Cost of Revenue | $12.39M | $4.05M | $2.30M |
| **Gross Profit** | $20.94M | $15.44M | $16.85M |
| Research & Development | $1.57M | $2.81M | $2.00M |
| Selling, General & Admin | $17.84M | $11.64M | $11.46M |
| Total Operating Expenses | $19.41M | $14.45M | $13.46M |
| **Operating Income** | $1.53M | $990K | $3.38M |
| **EBITDA** | $2.43M | $1.53M | $3.72M |
| Interest Income | $410K | $123K | $41K |
| Interest Expense | -- | $495K | $2.1K |
| Income Before Tax | $1.67M | $889K | $3.42M |
| Income Tax Expense | $395K | $219K | $945K |
| **Net Income** | $1.28M | $670K | $2.48M |
| Basic EPS | $0.02 | $0.01 | -- |
| **Diluted EPS** | $0.02 | $0.01 | -- |
| Basic Shares Outstanding | 55.8M | 51.8M | -- |
| Diluted Shares Outstanding | 57.7M | 53.7M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $6.59M | $8.06M | $8.77M | $7.51M | $8.49M | $9.31M | $8.01M | $4.90M |
| Cost of Revenue | $3.52M | $4.13M | $4.26M | $3.38M | $3.35M | $3.00M | $2.66M | $1.11M |
| **Gross Profit** | $3.06M | $3.92M | $4.51M | $4.13M | $5.14M | $6.31M | $5.36M | $3.80M |
| Research & Development | $939K | $876K | $920K | $213K | $236K | $583K | $538K | $634K |
| Selling, General & Admin | $5.18M | $6.48M | $5.75M | $4.09M | $4.42M | $5.00M | $4.34M | $3.48M |
| Total Operating Expenses | $11.45M | $7.36M | $6.67M | $4.30M | $4.65M | $5.58M | $4.87M | $4.11M |
| **Operating Income** | -$8.39M | -$3.44M | -$2.16M | -$171K | $494K | $725K | $481K | -$316K |
| **EBITDA** | -$8.11M | -$3.12M | -$1.75M | $240K | $712K | $861K | $617K | -$180K |
| Interest Income | $65K | $70K | $67K | $105K | $112K | $108K | $85K | $29K |
| Interest Expense | $20K | -- | -- | -- | -- | -- | -- | $0 |
| Income Before Tax | -$9.25M | -$3.32M | -$2.07M | -$444K | $600K | $833K | $684K | -$111K |
| Income Tax Expense | -$2.15M | -$810K | -$480K | -$141K | $148K | $203K | $186K | $33K |
| **Net Income** | -$7.07M | -$2.51M | -$1.59M | -$303K | $452K | $631K | $499K | -$144K |
| Basic EPS | -$0.11 | -$0.04 | -$0.03 | -- | $0.01 | $0.01 | $0.01 | -- |
| **Diluted EPS** | -$0.11 | -$0.04 | -$0.03 | -- | $0.01 | $0.01 | $0.01 | -- |
| Basic Shares Outstanding | 63.1M | 62.8M | 57.4M | -- | 56.4M | 55.4M | 54.6M | -- |
| Diluted Shares Outstanding | 63.1M | 62.8M | 57.4M | -- | 58.8M | 55.6M | 57.0M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Cash & Cash Equivalents | $7.67M | $7.85M | $2.42M |
| **Cash & Short-Term Investments** | $7.67M | $7.85M | $2.42M |
| Accounts Receivable, Net | $756K | $1.65M | $2.24M |
| **Total Current Assets** | $16.16M | $10.78M | $6.86M |
| **Total Non-Current Assets** | $6.93M | $4.98M | $4.64M |
| **Total Assets** | $23.09M | $15.77M | $11.50M |
| Other Current Liabilities | $892K | -- | -- |
| **Total Current Liabilities** | $5.16M | $2.13M | $4.78M |
| **Total Non-Current Liabilities** | $821K | $468K | $629K |
| **Total Liabilities** | $5.98M | $2.60M | $5.41M |
| **Total Debt (incl. Leases)** | $140K | $207K | $265K |
| Retained Earnings | $5.22M | $3.94M | $3.27M |
| **Total Stockholders' Equity** | $17.11M | $13.17M | $6.09M |
| Total Equity | $17.11M | $13.17M | $6.09M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | -- | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M |
| **Cash & Short-Term Investments** | -- | $6.51M | $10.33M | $7.67M | $8.02M | $8.14M | $7.58M | $7.85M |
| Accounts Receivable, Net | $3.18M | $8.55M | $3.74M | $756K | $869K | $1.28M | $2.11M | $1.65M |
| **Total Current Assets** | $17.09M | $21.78M | $22.09M | $16.16M | $15.05M | $14.85M | $15.57M | $10.78M |
| **Total Non-Current Assets** | $10.94M | $7.85M | $6.88M | $6.93M | $7.71M | $7.32M | $5.76M | $4.98M |
| **Total Assets** | $28.03M | $29.63M | $28.97M | $23.09M | $22.76M | $22.18M | $21.33M | $15.77M |
| Other Current Liabilities | -- | -- | -- | $892K | $869K | $956K | $780K | -- |
| **Total Current Liabilities** | $15.15M | $9.99M | $7.05M | $5.16M | $5.24M | $5.39M | $6.75M | $2.13M |
| **Total Non-Current Liabilities** | $0 | $22K | $316K | $821K | $359K | $365K | $416K | $468K |
| **Total Liabilities** | $15.15M | $10.01M | $7.36M | $5.98M | $5.60M | $5.75M | $7.17M | $2.60M |
| **Total Debt (incl. Leases)** | $84K | $103K | $122K | $140K | $158K | $174K | $191K | $207K |
| Retained Earnings | -$5.95M | $1.12M | $3.63M | $5.22M | $5.52M | $5.07M | $4.44M | $3.94M |
| **Total Stockholders' Equity** | -- | -- | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M |
| Total Equity | $12.88M | $19.62M | $21.60M | $17.11M | $17.16M | $16.42M | $14.16M | $13.17M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| Net Income | $1.28M | $670K | $3.96M |
| Depreciation & Amortization | $901K | $541K | $339K |
| Stock-Based Compensation | $1.57M | $468K | -- |
| Change in Receivables | $907K | $587K | -$1.28M |
| **Operating Cash Flow** | $3.13M | $2.18M | $1.53M |
| **Investing Cash Flow** | -$3.13M | -$837K | -$1.94M |
| Common Stock Issued | -- | $8.21M | -- |
| **Financing Cash Flow** | -$187K | $4.09M | $1.34M |
| **Net Change in Cash** | -$179K | $5.43M | $928K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$7.11M | -$2.51M | -$1.59M | -$303K | $452K | $631K | $499K | -$144K |
| Depreciation & Amortization | $279K | $320K | $403K | $411K | $218K | $136K | $136K | $136K |
| Stock-Based Compensation | $729K | $959K | $367K | $77K | $293K | $708K | $493K | -- |
| Change in Receivables | $3.48M | -$4.81M | -$2.98M | $130K | $417K | $823K | -$463K | -$716K |
| **Operating Cash Flow** | -$1.05M | -$2.91M | -$3.32M | $451K | $674K | $1.48M | $527K | -$531K |
| **Investing Cash Flow** | -$842K | -$597K | -$362K | -$768K | -$745K | -$910K | -$703K | -$542K |
| Common Stock Issued | $0 | $0 | $6.38M | -- | $0 | $0 | $8.21M | -- |
| **Financing Cash Flow** | $5.50M | -$301K | $6.34M | -$37K | -$44K | -$8.2K | -$98K | $7.18M |
| **Net Change in Cash** | $3.61M | -$3.81M | $2.66M | -$354K | -$115K | $563K | -$274K | $6.10M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 |
| --- | --- | --- | --- |
| **Gross Margin** | 62.8% | 79.2% | 88.0% |
| **Operating Margin** | 4.6% | 5.1% | 17.7% |
| **Net Profit Margin** | 3.8% | 3.4% | 12.9% |
| Return on Equity (ROE) | 7.5% | 5.1% | 40.6% |
| Return on Assets (ROA) | 5.5% | 4.3% | 21.5% |
| Current Ratio | 3.13x | 5.06x | 1.43x |
| Quick Ratio | 1.63x | 4.46x | 0.97x |
| Debt to Equity | 0.01x | 0.02x | 0.04x |
| **Revenue Growth (YoY)** | +71.0% | +1.8% | -- |
| Gross Profit Growth (YoY) | +35.6% | -8.4% | -- |
| Operating Income Growth (YoY) | +54.4% | -70.7% | -- |
| **Net Income Growth (YoY)** | +90.7% | -72.9% | -- |
| EPS Growth (YoY) | +100.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | +44.0% | +42.3% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 50.5% | 53.9% | 58.9% | 62.8% | 67.1% | 71.0% | 74.4% | 79.2% |
| **Operating Margin** | -45.8% | -16.1% | -3.3% | 4.6% | 4.5% | 5.0% | 5.1% | 5.1% |
| **Net Profit Margin** | -37.1% | -12.0% | -2.4% | 3.8% | 4.7% | 5.1% | 4.8% | 3.4% |
| Return on Equity (ROE) | -- | -- | -3.7% | 7.5% | 8.4% | 8.3% | 7.5% | 5.1% |
| Return on Assets (ROA) | -40.9% | -13.3% | -2.8% | 5.5% | 6.3% | 6.1% | 5.0% | 4.3% |
| Current Ratio | 1.13x | 2.18x | 3.13x | 3.13x | 2.87x | 2.76x | 2.31x | 5.06x |
| Quick Ratio | -- | 1.51x | 2.00x | 1.63x | 1.70x | 1.75x | 1.43x | 4.46x |
| Debt to Equity | -- | -- | 0.01x | 0.01x | 0.01x | 0.01x | 0.01x | 0.02x |
| **Revenue Growth (YoY)** | -22.4% | -13.5% | +9.4% | +53.1% | +90.4% | +86.2% | +56.4% | -- |
| Gross Profit Growth (YoY) | -40.5% | -37.8% | -15.8% | +8.7% | +47.8% | +56.7% | +29.5% | -- |
| Operating Income Growth (YoY) | -1800.5% | -574.2% | -549.0% | -- | +12.5% | +35.5% | +44.6% | -- |
| **Net Income Growth (YoY)** | -1662.8% | -498.2% | -418.6% | -- | +20.2% | +86.6% | +395.9% | -- |
| EPS Growth (YoY) | -1200.0% | -500.0% | -400.0% | -- | 0.0% | 0.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -255.1% | -296.6% | -729.4% | -- | -68.2% | +17.0% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
